ReShape Lifesciences Inc (NASDAQ:RSLS)’s traded shares stood at 68.87 million during the latest session, with the company’s beta value hitting 1.28. At the last check today, the stock’s price was $3.16, to imply an increase of 38.00% or $0.87 in intraday trading. The RSLS share’s 52-week high remains $414.99, putting it -13032.59% down since that peak but still an impressive 29.43% since price per share fell to its 52-week low of $2.23.
Analysts have given a consensus recommendation of Buy for ReShape Lifesciences Inc (RSLS), translating to a mean rating of 1.00. Of 1 analyst(s) looking at the stock, 0 analyst(s) give RSLS a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy.
ReShape Lifesciences Inc (NASDAQ:RSLS) trade information
After registering a 38.00% upside in the latest session, ReShape Lifesciences Inc (RSLS) has traded red over the past five days. The 5-day price performance for the stock is -25.64%, and -49.44% over 30 days. With these gigs, the year-to-date price performance is -97.17%.
RSLS Dividends
ReShape Lifesciences Inc has its next earnings report out in July. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
